AMR Baber Research

Naperville, Illinois 60563

0 studies enrolling now · 1 studies all time

What they study most

Major Depressive Disorder

Studies at this site

• A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) — Completed